Since 2008, the University of California Davis School of Veterinary Medicine and Merck Animal Health have worked to cultivate a strong biosurveillance program.
New Data Reflects Impact of Antigenic Drift and What This Means for Influenza Vaccination Strategies
MADISON, N.J., April 7, 2021 – For the second year in a row, equine influenza cases have surpassed all other infectious upper respiratory diseases in horses.¹ The incidence of equine influenza virus (EIV) has been trending upward since 2008, with considerable spikes in recent years.¹
,² As a leading research-driven biopharmaceutical company that develops, manufactures and markets a broad range of animal health medicines, products and services, Merck Animal Health has been actively working with researchers to study this trend, the reasons behind it and the best strategies for protecting horses against this highly contagious disease. Three findings are clear: